205 related articles for article (PubMed ID: 15376916)
1. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
Gupta AK; Berry C; Gupta M; Curtis A
IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
Gupta AK; Curtis AS
Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
[TBL] [Abstract][Full Text] [Related]
3. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture.
Gupta AK; Curtis AS
J Mater Sci Mater Med; 2004 Apr; 15(4):493-6. PubMed ID: 15332623
[TBL] [Abstract][Full Text] [Related]
4. The influence of elastin-coated 520-nm- and 20-nm-diameter nanoparticles on human fibroblasts in vitro.
Berry CC; Rudershausen S; Teller J; Curtis AS
IEEE Trans Nanobioscience; 2002 Sep; 1(3):105-9. PubMed ID: 16696299
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
Gupta AK; Gupta M
Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
7. The effect of silica nanoparticulate coatings on cellular response.
Cousins BG; Doherty PJ; Williams RL; Fink J; Garvey MJ
J Mater Sci Mater Med; 2004 Apr; 15(4):355-9. PubMed ID: 15332599
[TBL] [Abstract][Full Text] [Related]
8. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
Berry CC; Wells S; Charles S; Aitchison G; Curtis AS
Biomaterials; 2004 Oct; 25(23):5405-13. PubMed ID: 15130725
[TBL] [Abstract][Full Text] [Related]
9. Uptake of silica-coated nanoparticles by HeLa cells.
Xing X; He X; Peng J; Wang K; Tan W
J Nanosci Nanotechnol; 2005 Oct; 5(10):1688-93. PubMed ID: 16245529
[TBL] [Abstract][Full Text] [Related]
10. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
Berry CC; Wells S; Charles S; Curtis AS
Biomaterials; 2003 Nov; 24(25):4551-7. PubMed ID: 12950997
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells.
Kumar CS; Leuschner C; Doomes EE; Henry L; Juban M; Hormes J
J Nanosci Nanotechnol; 2004 Mar; 4(3):245-9. PubMed ID: 15233083
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes.
Balthasar S; Michaelis K; Dinauer N; von Briesen H; Kreuter J; Langer K
Biomaterials; 2005 May; 26(15):2723-32. PubMed ID: 15585276
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and characterization of polymer coated iron oxide microspheres.
Ramanujan RV; Chong WT
J Mater Sci Mater Med; 2004 Aug; 15(8):901-8. PubMed ID: 15477742
[TBL] [Abstract][Full Text] [Related]
14. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents.
Shieh DB; Cheng FY; Su CH; Yeh CS; Wu MT; Wu YN; Tsai CY; Wu CL; Chen DH; Chou CH
Biomaterials; 2005 Dec; 26(34):7183-91. PubMed ID: 15964622
[TBL] [Abstract][Full Text] [Related]
15. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
16. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
17. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts.
Gupta AK; Gupta M; Yarwood SJ; Curtis AS
J Control Release; 2004 Mar; 95(2):197-207. PubMed ID: 14980768
[TBL] [Abstract][Full Text] [Related]
18. Functionalization of iron oxide nanoparticles with biosurfactants and biocompatibility studies.
Sangeetha J; Thomas S; Arutchelvi J; Doble M; Philip J
J Biomed Nanotechnol; 2013 May; 9(5):751-64. PubMed ID: 23802405
[TBL] [Abstract][Full Text] [Related]
19. Long-term live cells observation of internalized fluorescent Fe@C nanoparticles in constant magnetic field.
Garanina A; Kireev I; Zhironkina O; Strelkova O; Shakhov A; Alieva I; Davydov V; Murugesan S; Khabashesku V; Majouga A; Agafonov V; Uzbekov R
J Nanobiotechnology; 2019 Feb; 17(1):27. PubMed ID: 30728022
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of silica-embedded iron oxide nanoparticles for magnetic resonance imaging.
Yan F; Xu H; Anker J; Kopelman R; Ross B; Rehemtulla A; Reddy R
J Nanosci Nanotechnol; 2004; 4(1-2):72-6. PubMed ID: 15112544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
